1. Home
  2. BNL vs ALKS Comparison

BNL vs ALKS Comparison

Compare BNL & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

HOLD

Current Price

$19.94

Market Cap

3.8B

Sector

Real Estate

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$35.25

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNL
ALKS
Founded
2007
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
4.5B
IPO Year
2008
2012

Fundamental Metrics

Financial Performance
Metric
BNL
ALKS
Price
$19.94
$35.25
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$20.22
$43.43
AVG Volume (30 Days)
3.8M
1.7M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
5.87%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$454,138,000.00
$1,475,899,000.00
Revenue This Year
$7.93
$24.26
Revenue Next Year
$5.45
$4.47
P/E Ratio
$82.15
$25.31
Revenue Growth
5.17
N/A
52 Week Low
$15.28
$25.17
52 Week High
$20.48
$36.56

Technical Indicators

Market Signals
Indicator
BNL
ALKS
Relative Strength Index (RSI) 55.68 59.55
Support Level $19.72 $27.65
Resistance Level $20.48 $36.40
Average True Range (ATR) 0.34 1.01
MACD -0.06 0.04
Stochastic Oscillator 52.89 60.06

Price Performance

Historical Comparison
BNL
ALKS

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: